AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05081232 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MLG (Multi-Layered Perinatal Issue Allograft) Allograft
Description: MLG allografts contains more than 450 bioactive proteins including growth factors and cytokines known to modulate inflammation and promote tissue healing.~MLG is supplied as sterile sheets having dimensions of 2cm x 2cm and a thickness of approximately 0.8-1.0mm thick.~Participants receiving MLG will have it placed around the neurovascular bundle. Placement of the graft should not take over 5 minutes of time to impact overall surgical time length significantly.
Study NCT05518357 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LILRB4 STAR-T
Description: Subjects with relapsed/refractory acute myeloid leukemia will be enrolled in the study, and Subjects will receive cytoreductive chemotherapy with cyclophosphamide and fludarabine on days -5, -4 and -3 followed by infusion of STAR-T cells. STAR-T cells will be intravenously infused with a escalated dose of 1E6#3E6#1E7 cells/kg。
Study NCT06383988 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Support for Caregiver - Generic List
Description: Receive a generic resource list
Study NCT06383988 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Support for Caregiver - Personalized List
Description: Receive personalized resource list
Study NCT06383988 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention - CONNECT
Description: Receive access to CONNECT tool
Study NCT06383988 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigation
Description: Complete calls with caregiver navigator
Study NCT05852197 — intervention group
Intervention type: DRUG
Intervention: anticoagulant or antiplatelet drugs
Description: combination of anticoagulant or antiplatelet drugs
Study NCT04782570 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Verum TMS
Description: Intensity of 100% of the resting motor threshold with iTBS. 600 stimuli applied in bursts of three pulses at 50 Hz given every 200 ms. iTBS will be applied 20 times for 2 s every 10 s.
Study NCT04782570 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham TMS
Description: Sham stimulation with same protocol, but without magnetic stimulation
Study NCT05059145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate
Description: Vaginal cream 1%
Study NCT05059145 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluconazole
Description: 150 mg oral capsule
Study NCT06027658 — intervention group
Intervention type: BEHAVIORAL
Intervention: RECREATION therapy
Description: Dance as therapy program with speech and movement co-therapy via body activity.
Study NCT04548349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Altreno
Description: Acne patients will be assigned to Altreno once daily.
Study NCT04548349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide
Description: Acne patients will be assigned to BPO leave-on gel once daily.
Study NCT05523427 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Two probiotic strains (L. plantarum and L. acidophilus)
Description: A capsule containing the L. plantarum and L. acidophilus strains is to be administered twice daily for three months in addition to the standard treatment of IBS.
Study NCT04826367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation-based relaxation exercise group (EG)
Description: the participants in this group will perform the relaxation exercises thrice a week, for 6 weeks.
Study NCT04658134 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glycine
Description: Oral glycine tablets (100 mg/kg/day) in divided doses
Study NCT05512585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: awake prone positioning with advanced respiratory support (high-flow nasal cannula or continuous positive airway pressure)
Description: in this group, healthy subjects will stay in prone position for 20 mins with respiratory support of high-flow nasal cannula or CPAP
Study NCT05512585 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: awake prone positioning with advanced respiratory support (high-flow nasal cannula or continuous positive airway pressure)
Description: in this group, healthy subjects will stay in prone position for 20 mins with respiratory support of high-flow nasal cannula or CPAP
Study NCT05970042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GameDay Ready
Description: GameDay Ready is a 12-week, group-based behavioral weight management program in which participants will meet in-person once per week at a publicly accessible walking track. The GameDay Ready program promotes increasing physical activity, reducing sedentary time, and improving dietary habits through education, behavioral self-monitoring, and goal setting. Each 60-minute intervention session includes a brief educational component followed by a group discussion of weekly progress. Following a short warmup walk, participants engage in group-based competitive physical activities and then a short cooldown walk. Participants then set individual and group-based goals for the upcoming week and discuss strategies for overcoming barriers to achieving goals. The program is sensitive to intersectional influences of gender, race, and rurality on health; and strategies to enhance motivation are threaded throughout the program.
Study NCT05970042 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking and General Health Education
Description: Participants receiving the comparison program will complete a 12-week walking and general health education program. Group sessions meet once per week at a publicly accessible walking track, and each 60-minute session consists of a brief educational component on a health topic followed by walking and socializing during the remainder of the session.
Study NCT05275231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions (ILIs)
Description: Intensive lifestyle interventions (ILIs) is a group-based programs designed to promote weight loss through a combination of diet, activity, and behavior change, decrease Type 2 Diabetes (T2D) incidence in people with prediabetes and reduced complications among people with T2D.
Study NCT05275231 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intensive lifestyle interventions (ILIs)
Description: Intensive lifestyle interventions (ILIs) is a group-based programs designed to promote weight loss through a combination of diet, activity, and behavior change, decrease Type 2 Diabetes (T2D) incidence in people with prediabetes and reduced complications among people with T2D.
Study NCT06294717 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises will be applied.
Description: Progressive relaxation exercises will be not applied.
Study NCT06227039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation on
Description: Mechanical stimulus is provided to the patient through a vibroacoustic device via vibration around the neck.
Study NCT06227039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented Reality on
Description: Visual stimulus is provided through augmented reality glasses in the form of a game.
Study NCT06227039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation off
Description: Vibroacoustic device is worn but turned off.
Study NCT06227039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Augmented reality off
Description: Augmented reality glasses are worn but turned off.
Study NCT04908514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADX-629
Description: ADX-629 administered orally twice daily (BID) for approximately 12 weeks.
Study NCT05314231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALXN1720
Description: All enrolled participants will receive a single dose of ALXN1720 on Day 1 followed by a Post-treatment and Follow-up Period (92 days).
Study NCT05269693 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brief Hope Intervention
Description: The BHI consisted of 4 one-on-one sessions: 2 (1 hr) face- to-face sessions, and 2 (30 min) telephone follow-up sessions
Study NCT04759625 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Novel biscuit enriched with mushroom powder containing 3g of β-glucans
Description: Daily consumption of a novel biscuit enriched with mushroom powder containing 3g of β-glucans
Study NCT04759625 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo biscuit
Description: Daily consumption of placebo biscuit
Study NCT06167395 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beta Alanine high dose
Description: Subjects should consume 4 intakes of 5 g of beta alanine every 3 hours each day.
Study NCT06167395 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beta Alanine low dose
Description: Subjects should consume 4 intakes of 2,5 g of beta alanine every 3 hours each day.
Study NCT06167395 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control product
Description: Subjects should consume 4 intakes of 2,5 g of wheat semolina every 3 hours each day.
Study NCT05317312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MR-107A-02
Description: MR-107A-02 oral tablet
Study NCT04489199 — intervention group
Intervention type: OTHER
Intervention: Questionnaire and semi-structured interview
Description: questionnaire submitted by telephone 3 months, 6 months, 1 year, 5 years, and 10 years after the stroke/TIA. interview duration 20 to 40 minutes
Study NCT05207020 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Glycemia estimated by exhaled air analyzer
Description: Measurement of volatile compounds in the air exhaled by the volunteer on 3 different MIBs (3 breaths in total) at 7 times: T0, 30min, 1H, 1H30, 2H, 2H30, 3H after test meal
Study NCT05207020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: The questionnaire focuses on the methods and feelings of the blood glucose self-monitoring that he is currently carrying out, a first feedback on user experience on the operation of the prototype and the collection of his expectations for a future commercial device
Study NCT05207020 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Veinous glycemia
Description: Measurement of the veinous glycemia at 7 times: T0, 30min, 1H, 1H30, 2H, 2H30, 3H after test meal
Study NCT05207020 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Capillary glycemia
Description: 7-step capillary glycemia measurement: T0, 30min, 1H, 1H30, 2H, 2H30, 3H after test meal
Study NCT05207020 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: constitution biological collection
Description: Sampling for storage of serum at 7 times: T0, 30min, 1H, 1H30, 2H, 2H30, 3H after test meal
Study NCT05207020 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Single blood sample before mealtimes for HbA1C molecular analysis
Study NCT05207020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test meal
Description: taking a test meal before the various blood sugar measurements
Study NCT06583863 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Echinacea Extract
Description: 175 mg of Echinacea extract was provided as an immunlant therapy twice daily.
Study NCT05317312 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral tablet
Study NCT05900674 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reteplase Injection
Description: To test the single dose of reteplase (9 U) and Maximum dose (18 U) in acute ischemic stroke patients.
Study NCT06583863 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MetroNIDAZOLE 500 MG Oral Tablet [Flagyl]
Description: 500 mg of metronidazole was provided as an oral tablets twice daily
Study NCT05368194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isocaloric Unprocessed Diet
Description: Intervention consists of an unprocessed diet meeting the Nordic and Australian Dietary Guidelines for food groups and micronutrients, wherein participants will be supplied with food providing kilocalories (kcal) in accordance with their nutritional needs as calculated based on theSchofield equation based on their weight, activity multiplier, and age at baseline. Almost all food and beverage products provided during this treatment to fall into the category of unprocessed/minimally processed foods and processed culinary ingredients in accordance with the NOVA classification system.
Study NCT05368194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isocaloric Processed Diet
Description: Intervention consists of a processed diet based on the dietary intake pattern resembling a processed western dietary intake pattern representative of the typical intake pattern of American men aged 19- 50, wherein participants will be supplied with food providing kcals in accordance with their nutritional needs as calculated based on the Schofield equation based on their height, weight, activity multiplier, and age at baseline. Almost all food and beverage products provided during this treatment to fall into the category of processed foods and ultra-processed foods in accordance with the NOVA classification system.
Study NCT05368194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Excess Calorie Unprocessed Diet
Description: Intervention consists of an unprocessed diet meeting the Nordic and Australian Dietary Guidelines for food groups and micronutrients, wherein participants will be supplied with food providing kilocalories (kcal) in accordance with their nutritional needs as calculated based on theSchofield equation based on their weight, activity multiplier, and age at baseline, plus an excess of 500 kcal per day. Almost all food and beverage products provided during this treatment to fall into the category of unprocessed/minimally processed foods and processed culinary ingredients in accordance with the NOVA classification system.
Study NCT05368194 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Excess Calorie Processed Diet
Description: Intervention consists of a processed diet based on the dietary intake pattern resembling a processed western dietary intake pattern representative of the typical intake pattern of American men aged 19- 50, wherein participants will be supplied with food providing kcals in accordance with their nutritional needs as calculated based on the Schofield equation based on their height, weight, activity multiplier, and age at baseline, plus an excess of 500 kcal per day. Almost all food and beverage products provided during this treatment to fall into the category of processed foods and ultra-processed foods in accordance with the NOVA classification system.
Study NCT05932472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin
Description: Aspirin at currently prescribed dose
Study NCT05932472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Aspirin at currently prescribed dose
Study NCT04736381 — intervention group
Intervention type: DRUG
Intervention: Belatacept Injection [Nulojix]
Description: Drugs administrated are part of the usual care
Study NCT05971537 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: antibiotic lock
Description: In the intervention arm, in addition to the appropriate IP antibiotics, an antibiotic-lock will be prepared by the same antibiotics. We will follow the suggested data used in hemodialysis catheter for the concentration of different antibiotics to prepare the locking solution . Some commonly used antibiotics for the treatment of PD peritonitis with their suggested concentrations in the antibiotic-lock are quoted as below:~Cefazolin 10mg/mL Ceftazidime 10mg/mL Vancomycin 10mg/mL Gentamicin 5mg/mL Tienam 50mg/mL
Study NCT05971537 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: conventional IP antibiotics
Description: In the control arm, appropriate IP antibiotics are to be continued. The dosage and duration of antibiotics will fully follow the recommendation from the latest International Society for Peritoneal Dialysis (ISPD) peritonitis guidelines
Study NCT05343377 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: circulate free methylated EBV DNA
Description: Accuracy of circulating free methylated EBV DNA in predicting 2-year PFS
Study NCT05058079 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intraoperative Hand Held
Description: Intraoperative hand holding
Study NCT05897229 — intervention group
Intervention type: OTHER
Intervention: Analysis of costs with patient care during hospitalization
Description: Analysis of direct costs with supplies, medications, diets, laboratory tests and imaging exams, and invasive procedures such as mechanical ventilation, dialysis, and the use of vasoactive drugs.-analysis of costs referring to working hours of physicians, nurses and physical therapists in each unit normalized for the same number of beds.- cost minimization and consequential cost analysis.
Study NCT05900674 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reteplase Injection
Description: To test the single dose of reteplase (9 U) and Maximum dose (18 U) in acute ischemic stroke patients.
Study NCT05906433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Kenalog with bupivacaine Injection
Description: Indications, relevant for this study include Kenalog injection for knee pain from osteoarthritis or inflammatory arthritis. A single injection to a patient who has no known allergies to anesthetic or corticosteroids would be administered during a scheduled clinical visit.
Study NCT05036876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Degludec
Description: Treatment with insulin degludec when compared to insulin glargine U-300 will result in similar blood glucose control in hospitalized patients with type 2 diabetes.
Study NCT05036876 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glargine U300
Description: Treatment with insulin glargine U300 when compared to insulin degludec will result in similar blood glucose control in hospitalized patients with type 2 diabetes.
Study NCT05637931 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: plexinD1
Description: evaluation of the serum level of plexinD1
Study NCT05395325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: Kinesio tape would be applied (1)over the extensor muscles of the affected hand for facilitating the extension of hand. We will apply the tape from the upper 1/3 length of dorsal side of the forearm and split the tape into five equal bars to the distal interphalangeal joint of each finger along the finger bones. (2) from above the scapula spine to the medial deltoid. (3) from medial border of scapula to anterior deltoid.This intervention would be executed for five days per week for three weeks.
Study NCT05395325 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesiotaping
Description: Kinesio tape would be applied (1)over the extensor muscles of the affected hand for facilitating the extension of hand. We will apply the tape from the upper 1/3 length of dorsal side of the forearm and split the tape into five equal bars to the distal interphalangeal joint of each finger along the finger bones. (2) from above the scapula spine to the medial deltoid. (3) from medial border of scapula to anterior deltoid.This intervention would be executed for five days per week for three weeks.
Study NCT05395325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand rehabilitation program
Description: In the thirty-minute hand rehabilitation program, a motor-relearning theory would be implemented into the intervention by teaching the participants how to use their upper limb properly without any compensatory motions. Therefore, for establishing a correct movement pattern, an occupational therapist would provide a hand-guided activity, in which the participants could practice reaching movement as well as hand grasp and release in a more natural way. Besides, the therapist would also help the patients release their muscle tone by stretching the spastic muscles for five minutes before and after this hand rehabilitation period
Study NCT05395325 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Hand rehabilitation program
Description: In the thirty-minute hand rehabilitation program, a motor-relearning theory would be implemented into the intervention by teaching the participants how to use their upper limb properly without any compensatory motions. Therefore, for establishing a correct movement pattern, an occupational therapist would provide a hand-guided activity, in which the participants could practice reaching movement as well as hand grasp and release in a more natural way. Besides, the therapist would also help the patients release their muscle tone by stretching the spastic muscles for five minutes before and after this hand rehabilitation period
Study NCT05395325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Steroid injection
Description: all the steroid injection would be executed by physicians. The 23G needles would be used for the injections. The examiners would be clear and familiar with the protocol, and the injections would be executed for only one time during the study period in experimental group.
Study NCT06182969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APG-2575
Description: Take orally once daily (QD) for 12 weeks.
Study NCT06182969 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Take orally once daily (QD) for 12 weeks.
Study NCT05822180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NANOS1 , argent colloïdal ,
Description: orally, during 5 day
Study NCT05822180 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NANOS1 , argent colloïdal ,
Description: orally, during 5 day